Multicenter prospective study on the efficacy and safety of PTGBA in acute cholecystitis on anti-thrombotic therapy

Multicenter prospective study on the efficacy and safety of PTGBA in acute cholecystitis on anti-thrombotic therapy - Multicenter prospective study on the efficacy and safety of PTGBA in acute cholecystitis on anti-thrombotic therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022987

Enrollment

Registered

2016-07-02

Start date

2016-07-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cholecystitis

Interventions

PTGBA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with anti-thrombotic therapy 2) Moderate or severe acute cholecystitis 3) There is no recommend of emergency surgery 4) age =>20

Exclusion criteria

Exclusion criteria: 1) No informed concent 2) Patients with mild cholecystitis 3) Patients with perforation of the gallbladder 4) Patients with pericholecystic abscess 5) Patients with gallbladder cancer 6) Patients with cholangitis 7) Ascitic fluid 8) Pregnancy 9) Cases regarded by doctors as inappropriate for the enrollment for some reasons

Design outcomes

Primary

Measure	Time frame
Efficacy	—

Secondary

Measure	Time frame
Procedure success rate Safty	—

Countries

Japan

Contacts

Public ContactKosuke Okuwaki

Kitasato University School of Medicine Department of Gastroenterology

kokuwaki@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026